M2
← Portfolio

Equity Research · Realized Position

ServiceNow

NOW · · Enterprise Software

Rating

Realized — Stopped Out

Entry

$135.00

Exit

$93.00

Realized Return

−31.1%

Holding Period

Jan – Apr 2026

Quan Pham, Senior Analyst · M’Squared Capital Research · Closed 9 Apr 2026

A quality compounder bought into a growth wobble at the wrong moment.

Summary

We owned ServiceNow for agentic-AI workflow monetization on the stickiest platform in enterprise software. A growth-optics wobble and multiple compression hit the position, and we stopped at $93 from $135 — a timing loss on a franchise we respect.

Business Overview

ServiceNow provides enterprise workflow automation across IT service and operations management, increasingly infused with generative and agentic AI.

Investment Thesis

  1. 01

    Franchise quality

    Best-in-class retention and a genuine agentic-AI monetization path remain intact. The business was never the problem.

  2. 02

    The mistake

    We bought into a decelerating-optics window at a premium multiple, and the de-rating came before our catalyst.

  3. 03

    Discipline held

    We cut at the stop and will re-underwrite on stabilization and a better price.

Valuation & Price Target

We stopped at $93, roughly −31%. A timing and valuation loss, not a thesis break.

Catalysts

  • A cRPO and billings-optics wobble
  • Software-multiple compression
  • Macro IT-budget caution

Key Risks

  • Premium-multiple sensitivity
  • Poor entry timing

Bottom Line

A great business bought at the wrong moment. Realized −31.1%; we would revisit.

This note is the opinion of M’Squared Capital and is provided for informational purposes only. It is not investment advice, nor an offer or solicitation to buy or sell any security. Price targets and entry and exit levels reflect the firm’s proprietary views and realized transactions; they are not forecasts of future results. The firm may hold, add to, reduce, or close any position at any time without notice. Past performance is not indicative of future results.